Genedrive ® MT-RNR1 to commence roll out in Greater Manchester Project to follow NICE final recomendations scheduled for end of this month
Versarien PLC (AIM:VRS) Further re Resignation of Chief Executive Officer
Versarien plc (AIM: VRS), the advanced materials engineering group, announces that further to the announcement made on 10 March 2023, the Company confirms that Neill Ricketts’ resignation as Chief Executive
According to the US Department of Energy, it is probable that Covid-19 originated from a laboratory leak.
According to the Wall Street Journal, a recently updated and classified 2021 US Department of Energy study, provided to senior American lawmakers and the White House, suggests that the virus
Genedrive PLC (AIM:GDR) AIHL test preliminary recommendation by NICE
Antibiotic Induced Hearing Loss test receives preliminary recommendation by NICE NICE enters public consultation phase of Early Value Assessment of the Genedrive® MT-RNR1 System
ValiRx PLC (AIM:VAL) Operational Update
London, UK – ValiRx Plc (AIM: VAL), a life science company focusing on early-stage cancer therapeutics and women’s health, is pleased to announce today the signature of a lease for
ValiRx PLC (AIM:VAL) Launch of Broker Offer to raise a maximum of £500,000
Launch of Broker Offer to raise a maximum of £500,000
Big Oil Bets Billions on Global Climate Catastrophe
According to Carbon Tracker (a non-profit think tank), the world’s largest oil producers are spending billions on fossil fuel projects. These will be required if the world fails to meet
After four days of decline, oil rebounded from 2022 lows
After four days of decline, oil rebounded on Thursday. This was aided by the hope that China’s anti-COVID measures will ease and signs that some tankers carrying Russian crude oil
Oil falls close to 2022 lows on economic worries
On Wednesday, oil fell, with Brent crude close to its lowest level this year. This was due to concerns about recession and the easing of fears that a Western ban
ValiRx PLC (AIM:VAL) Quarterly Operational and Strategy Update
London, UK – ValiRx Plc (AIM: VAL), a life science company focusing on early-stage cancer therapeutics and women’s health, today provides an update on operational activities and strategy.
Genedrive PLC (AIM:GDR) US FDA pre-submission for Genedrive MT-RNR1 kit
Genedrive file US FDA Pre-Submission for the Genedrive ® MT-RNR1 Product Range